Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06144840
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2023-11-17
Brief Title:
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
Sponsor:
Mitsubishi Tanabe Pharma America Inc
Organization:
Mitsubishi Tanabe Pharma America Inc
Study Overview
Official Title:
A Phase 3 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy Safety and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
INSPIRE
Brief Summary:
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms burning tingling itching or stinging associated with sunlight exposure in adults and adolescents with EPP or XLP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| jRCT2031230656 | REGISTRY | Japan Registry of Clinical Trials jRCT | None |